Exact Sciences markets Cologuard as a non-invasive, convenient test. The traditional method of testing for colorectal cancer ...

Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and ...

Chinese scientists may have developed a possible alternative to colonoscopies for detecting gastrointestinal diseases with a ...

Five AI-based technologies that can be used during a colonoscopy exam to help detect the early signs of bowel cancer have ...

The second-most common cancer in Malaysia may not have symptoms, which is why experts advocate checkups for early detection.

Abbott has announced a $23 billion acquisition of Exact Sciences, boosting its cancer diagnostics offerings with key tests ...

Abbott (NYSE: ABT) announced today that it agreed to acquire diagnostics maker Exact Sciences (Nasdaq:EXAS) for approximately ...

"Not all colon polyps are cancerous but all colon cancer starts as a polyp which is why everyone needs to know about them and ...

Abbott Laboratories to acquire cancer diagnostics company for $105 per share in deal valued at $21 billion. Closing expected Q2 2026.

The age that bowel cancer screening starts in the Channel Islands should be lowered according to someone who has the disease.

Studies have shown that cancer is more common in those who have crossed 45 age, thus, if you belong in the aforementioned age ...

Natera, Inc. (NTRA) 7th Annual Wolfe Research Healthcare Conference November 19, 2025 10:00 AM ESTCompany ParticipantsMike Brophy - Chief ...